Bristol-Myers Squibb Company announced that cumulative data from a trial demonstrate the long-term efficacy and safety of ORENCIA in adult rheumatoid arthritis patients.
Bristol-Myers Squibb Company announced that cumulative data from a trial demonstrate the long-term efficacy and safety of ORENCIA in adult rheumatoid arthritis patients.